8.35 USD
-0.07 (-0.83%)
8.35 USD
0 (0%)
Taking everything into account, JYNT scores 3 out of 10 in our fundamental rating. JYNT was compared to 101 industry peers in the Health Care Providers & Services industry. While JYNT seems to be doing ok healthwise, there are quite some concerns on its profitability. JYNT has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
JYNT had negative earnings in the past year.
In the past year JYNT had a positive cash flow from operations.
In multiple years JYNT reported negative net income over the last 5 years.
Each year in the past 5 years JYNT had a positive operating cash flow.
1.2 Ratios
JYNT has a Return On Assets (-1.40%) which is comparable to the rest of the industry.
JYNT has a Return On Equity of -4.27%. This is comparable to the rest of the industry: JYNT outperforms 47.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.4% | ||
| ROE | -4.27% | ||
| ROIC | N/A |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 78.26%, JYNT belongs to the top of the industry, outperforming 93.07% of the companies in the same industry.
In the last couple of years the Gross Margin of JYNT has declined.
JYNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.26% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
2. Health
2.1 Basic Checks
JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, JYNT has more shares outstanding
JYNT has more shares outstanding than it did 5 years ago.
There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
JYNT has an Altman-Z score of 2.72. This is not the best score and indicates that JYNT is in the grey zone with still only limited risk for bankruptcy at the moment.
JYNT has a Altman-Z score (2.72) which is comparable to the rest of the industry.
JYNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 2.72 |
ROIC/WACCN/A
WACC8.68%
2.3 Liquidity
JYNT has a Current Ratio of 1.83. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.83, JYNT is doing good in the industry, outperforming 72.28% of the companies in the same industry.
A Quick Ratio of 1.83 indicates that JYNT should not have too much problems paying its short term obligations.
JYNT has a better Quick ratio (1.83) than 75.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 99.03% over the past year.
The Revenue for JYNT has decreased by -24.15% in the past year. This is quite bad
The Revenue has been growing slightly by 1.36% on average over the past years.
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
3.2 Future
Based on estimates for the next years, JYNT will show a very strong growth in Earnings Per Share. The EPS will grow by 72.72% on average per year.
Based on estimates for the next years, JYNT will show a very negative growth in Revenue. The Revenue will decrease by -20.57% on average per year.
EPS Next Y98.84%
EPS Next 2Y91.55%
EPS Next 3Y72.72%
EPS Next 5YN/A
Revenue Next Year-54.02%
Revenue Next 2Y-28.81%
Revenue Next 3Y-20.57%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for JYNT. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 22.74, JYNT is valued on the expensive side.
JYNT's Price/Forward Earnings is on the same level as the industry average.
JYNT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.21.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 22.74 |
4.2 Price Multiples
JYNT's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 76.06 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
JYNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
JYNT's earnings are expected to grow with 72.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y91.55%
EPS Next 3Y72.72%
5. Dividend
5.1 Amount
No dividends for JYNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
8.35
-0.07 (-0.83%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners77.63%
Inst Owner Change-1.63%
Ins Owners8.65%
Ins Owner Change2.1%
Market Cap124.16M
Revenue(TTM)91.63M
Net Income(TTM)-970.20K
Analysts78.18
Price Target10.97 (31.38%)
Short Float %3.97%
Short Ratio5.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.07%
Min Revenue beat(2)-2.34%
Max Revenue beat(2)-1.81%
Revenue beat(4)0
Avg Revenue beat(4)-14.21%
Min Revenue beat(4)-51.14%
Max Revenue beat(4)-1.53%
Revenue beat(8)3
Avg Revenue beat(8)-6.24%
Revenue beat(12)3
Avg Revenue beat(12)-4.83%
Revenue beat(16)5
Avg Revenue beat(16)-4.04%
PT rev (1m)-27.73%
PT rev (3m)-27.73%
EPS NQ rev (1m)-54.29%
EPS NQ rev (3m)-46.67%
EPS NY rev (1m)0%
EPS NY rev (3m)50%
Revenue NQ rev (1m)-5.58%
Revenue NQ rev (3m)-5.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 22.74 | ||
| P/S | 1.36 | ||
| P/FCF | 76.06 | ||
| P/OCF | 40.43 | ||
| P/B | 5.47 | ||
| P/tB | 5.47 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.01
EYN/A
EPS(NY)0.37
Fwd EY4.4%
FCF(TTM)0.11
FCFY1.31%
OCF(TTM)0.21
OCFY2.47%
SpS6.16
BVpS1.53
TBVpS1.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.4% | ||
| ROE | -4.27% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 78.26% | ||
| FCFM | 1.78% |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
F-Score6
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 78.79% | ||
| Cap/Sales | 1.57% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 2.72 |
F-Score6
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)57.36%
Cap/Depr(5y)93.23%
Cap/Sales(3y)6.25%
Cap/Sales(5y)6.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
EPS Next Y98.84%
EPS Next 2Y91.55%
EPS Next 3Y72.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
Revenue Next Year-54.02%
Revenue Next 2Y-28.81%
Revenue Next 3Y-20.57%
Revenue Next 5YN/A
EBIT growth 1Y-575.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year313.77%
EBIT Next 3Y73.96%
EBIT Next 5YN/A
FCF growth 1Y-85.24%
FCF growth 3Y6.31%
FCF growth 5Y15.29%
OCF growth 1Y-81.35%
OCF growth 3Y-12.05%
OCF growth 5Y4.6%
JOINT CORP/THE / JYNT FAQ
What is the ChartMill fundamental rating of JOINT CORP/THE (JYNT) stock?
ChartMill assigns a fundamental rating of 3 / 10 to JYNT.
What is the valuation status for JYNT stock?
ChartMill assigns a valuation rating of 3 / 10 to JOINT CORP/THE (JYNT). This can be considered as Overvalued.
How profitable is JOINT CORP/THE (JYNT) stock?
JOINT CORP/THE (JYNT) has a profitability rating of 3 / 10.
Can you provide the expected EPS growth for JYNT stock?
The Earnings per Share (EPS) of JOINT CORP/THE (JYNT) is expected to grow by 98.84% in the next year.